BioCentury
ARTICLE | Financial News

Idera amends follow-on

April 29, 2013 7:00 AM UTC

Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Cambridge, Mass. Business: Cancer, Infectious, Autoimmune Date announced: 4/23/13 Type: Follow-on To be raised: Up to $12.5 million Shares: TBD Price: TBD Und...